Back to search
FDAFDA · Food and drugs·Recall number D-0095-2023

Acyclovir Sodium Injection 1,000 mg per 20 mL* (50 mg/mL); Single Dose 20mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd, E. Windsor, NJ 08520; Made in India. NDC 55150-155-20

Published January 11, 2023 · Recall initiated: December 28, 2022

Summary

FDA records drug Class II recall D-0095-2023, published January 11, 2023 and initiated December 28, 2022. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 45,250 vials; Lot: Lot # AC22004, Expiry: 08/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Customer complaint of dark particles found inside the vial

What to do

Voluntary: Firm initiated · Letter

Get an email if ACYCLOVIR SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ACYCLOVIR SODIUM
Manufacturer
Eugia US LLC
Distributor
Nationwide in the USA
UPC
0355150155200
Lot
Lot # AC22004, Expiry: 08/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Acyclovir Sodium Injection 1,000 mg per 20 mL* (50 mg/mL); Single Dose 20mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd, E. Windsor, NJ 08520; Made in India. NDC 55150-155-20 recalled?

Yes. FDA published recall D-0095-2023 on January 11, 2023. Reported hazard: Presence of Particulate Matter: Customer complaint of dark particles found inside the vial

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ACYCLOVIR SODIUM. UPC: 0355150155200.